$20,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advocating for medicines to protect pigs from harmful diseases and lower the mortality rate of newborn pigs"
You can find more data on corporate lobbying on Quiver Quantitative.
PAHC Insider Trading Activity
PAHC insiders have traded $PAHC stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $PAHC stock by insiders over the last 6 months:
- JACK BENDHEIM (President and CEO) has made 0 purchases and 10 sales selling 84,480 shares for an estimated $3,417,596.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PAHC Hedge Fund Activity
We have seen 99 institutional investors add shares of PAHC stock to their portfolio, and 92 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PZENA INVESTMENT MANAGEMENT LLC removed 723,830 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $18,486,618
- EXODUSPOINT CAPITAL MANAGEMENT, LP added 680,383 shares (+inf%) to their portfolio in Q2 2025, for an estimated $17,376,981
- CAPRICORN FUND MANAGERS LTD added 252,928 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,233,466
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 218,894 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,856,451
- BLACKROCK, INC. removed 201,106 shares (-5.4%) from their portfolio in Q2 2025, for an estimated $5,136,247
- AMERICAN CENTURY COMPANIES INC removed 198,512 shares (-46.6%) from their portfolio in Q2 2025, for an estimated $5,069,996
- RANGER INVESTMENT MANAGEMENT, L.P. added 179,975 shares (+101.1%) to their portfolio in Q2 2025, for an estimated $4,596,561
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PAHC Analyst Ratings
Wall Street analysts have issued reports on $PAHC in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Underperform" rating on 08/29/2025
To track analyst ratings and price targets for PAHC, check out Quiver Quantitative's $PAHC forecast page.
PAHC Price Targets
Multiple analysts have issued price targets for $PAHC recently. We have seen 3 analysts offer price targets for $PAHC in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Derik De Bruin from B of A Securities set a target price of $27.0 on 08/29/2025
- Ekaterina Knyazkova from JP Morgan set a target price of $35.0 on 07/07/2025
- Erin Wright from Morgan Stanley set a target price of $26.0 on 06/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
